Cargando…

A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs

Continuous glucose monitoring (CGM) is used to help patients with diabetes and their healthcare providers more effectively manage care. CGM use is expanding to all healthcare settings where pharmacists practice and new pharmacy graduates may increasingly be asked to assist patients utilizing CGM dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Knezevich, Emily, Fuji, Kevin T., Larson, Krysta, Muniz, Gabrielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785425/
https://www.ncbi.nlm.nih.gov/pubmed/36548330
http://dx.doi.org/10.3390/pharmacy10060174
_version_ 1784858045575069696
author Knezevich, Emily
Fuji, Kevin T.
Larson, Krysta
Muniz, Gabrielle
author_facet Knezevich, Emily
Fuji, Kevin T.
Larson, Krysta
Muniz, Gabrielle
author_sort Knezevich, Emily
collection PubMed
description Continuous glucose monitoring (CGM) is used to help patients with diabetes and their healthcare providers more effectively manage care. CGM use is expanding to all healthcare settings where pharmacists practice and new pharmacy graduates may increasingly be asked to assist patients utilizing CGM devices and assess diabetes management through the interpretation of CGM data. The purpose of this study was to describe CGM education across Doctor of Pharmacy (Pharm.D.) programs in the United States. An online survey was administered to 139 accredited Pharm.D. programs. Information was solicited about CGM education, including curricular placement, course type, hands-on experience, and credential(s) of faculty providing the education. Fifty-seven programs responded with 51 (89.5%) providing CGM education for a median of 1.0 h. Of programs providing detailed responses, content was delivered in required (60.4%) or elective (45.8%) lectures as well as experiential settings (41.7%). Education occurred most frequently in the third year (58.3%), followed by the second (43.8%) and fourth (37.5%) years. Thirty-one (66.0%) programs were taught by a faculty member with an advanced diabetes credential. The results from this study confirm that there is an ongoing need to examine optimal amount, timing, and methods for providing CGM education.
format Online
Article
Text
id pubmed-9785425
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97854252022-12-24 A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs Knezevich, Emily Fuji, Kevin T. Larson, Krysta Muniz, Gabrielle Pharmacy (Basel) Article Continuous glucose monitoring (CGM) is used to help patients with diabetes and their healthcare providers more effectively manage care. CGM use is expanding to all healthcare settings where pharmacists practice and new pharmacy graduates may increasingly be asked to assist patients utilizing CGM devices and assess diabetes management through the interpretation of CGM data. The purpose of this study was to describe CGM education across Doctor of Pharmacy (Pharm.D.) programs in the United States. An online survey was administered to 139 accredited Pharm.D. programs. Information was solicited about CGM education, including curricular placement, course type, hands-on experience, and credential(s) of faculty providing the education. Fifty-seven programs responded with 51 (89.5%) providing CGM education for a median of 1.0 h. Of programs providing detailed responses, content was delivered in required (60.4%) or elective (45.8%) lectures as well as experiential settings (41.7%). Education occurred most frequently in the third year (58.3%), followed by the second (43.8%) and fourth (37.5%) years. Thirty-one (66.0%) programs were taught by a faculty member with an advanced diabetes credential. The results from this study confirm that there is an ongoing need to examine optimal amount, timing, and methods for providing CGM education. MDPI 2022-12-16 /pmc/articles/PMC9785425/ /pubmed/36548330 http://dx.doi.org/10.3390/pharmacy10060174 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Knezevich, Emily
Fuji, Kevin T.
Larson, Krysta
Muniz, Gabrielle
A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title_full A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title_fullStr A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title_full_unstemmed A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title_short A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
title_sort cross-sectional survey study examining the provision of continuous glucose monitoring education in u.s. doctor of pharmacy programs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785425/
https://www.ncbi.nlm.nih.gov/pubmed/36548330
http://dx.doi.org/10.3390/pharmacy10060174
work_keys_str_mv AT knezevichemily acrosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT fujikevint acrosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT larsonkrysta acrosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT munizgabrielle acrosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT knezevichemily crosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT fujikevint crosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT larsonkrysta crosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms
AT munizgabrielle crosssectionalsurveystudyexaminingtheprovisionofcontinuousglucosemonitoringeducationinusdoctorofpharmacyprograms